Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol
Author(s) -
Erin C. Hanlon,
Esra Tasali,
Rachel Leproult,
Kara L. Stuhr,
Elizabeth M. Doncheck,
Harriet de Wit,
Cecilia J. Hillard,
Eve Van Cauter
Publication year - 2016
Publication title -
sleep
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.222
H-Index - 207
eISSN - 1550-9109
pISSN - 0161-8105
DOI - 10.5665/sleep.5546
Subject(s) - endocannabinoid system , appetite , endocrinology , medicine , sleep restriction , sleep (system call) , circadian rhythm , 2 arachidonoylglycerol , wakefulness , obesity , crossover study , sleep deprivation , cannabinoid receptor , psychiatry , electroencephalography , receptor , computer science , agonist , operating system , placebo , alternative medicine , pathology
Increasing evidence from laboratory and epidemiologic studies indicates that insufficient sleep may be a risk factor for obesity. Sleep curtailment results in stimulation of hunger and food intake that exceeds the energy cost of extended wakefulness, suggesting the involvement of reward mechanisms. The current study tested the hypothesis that sleep restriction is associated with activation of the endocannabinoid (eCB) system, a key component of hedonic pathways involved in modulating appetite and food intake.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom